Four decades of anal cancer in Tasmania, Australia: what do the case data tell us?
Steve Simpson
+ Author Affiliations
- Author Affiliations
A Menzies Research Institute Tasmania, University of Tasmania, Private Bag 23, Hobart, Tas. 7000, Australia.
B School of Medicine, University of Tasmania, Private Bag 96, Hobart, Tas. 7000, Australia.
C Corresponding author. Email: richard.turner@utas.edu.au
Sexual Health 9(3) 213-219 https://doi.org/10.1071/SH11002
Submitted: 10 January 2011 Accepted: 20 June 2011 Published: 24 August 2011
Abstract
Background: Anal cancer is a rare cancer analogous to cervical cancer, largely caused by exposure to oncogenic human papillomavirus. We have sought to study this disease in the epidemiologically distinct population of Tasmania. Methods: Medical records at all tertiary and secondary referral centres in Tasmania were audited for records with corresponding International Classification of Diseases (ICD)-10 codes. Statistical significances of trends were evaluated using Fisher’s exact test, logistic regression or linear regression. Results: Of ~1350 screening records, 170 cases of anal cancer were found with patient presentation during 1973–2010, corresponding to 132 patients. This cohort was mostly female (66.7%), with squamous cell histology (81.8%) and anal canal primaries (72.0%). Most cases were detected at Stage II or below and the majority remained disease-free after treatment. Relatively few cases had documentation of typical risk factors for anal cancer, such as HIV seropositivity, a history of cancer or smoking. After 2000, there was a trend towards a lower stage at presentation, correlating with an increased 5-year survival. After 2000, no anal margin tumours presented beyond Stage II; nearly half were detected in situ and none were fatal. For anal canal tumours, there was virtually no change in the mean stage at detection or in survival. Conclusion: This is the first case series of anal cancer in Tasmania. We find that in many ways, including symptoms and pathology at presentation, epidemiology is typical. However, our cohort is distinct in its paucity of known risk groups, including HIV-positive people, those with a history of cancer and smokers.
Additional keywords: case series, descriptive epidemiology, epidemiology, human papillomavirus, squamous cell carcinoma.
References
[1] Palefsky JM, Rubin M. The epidemiology of anal human papillomavirus and related neoplasia. Obstet Gynecol Clin North Am 2009; 36 187–200.| The epidemiology of anal human papillomavirus and related neoplasia.Crossref | GoogleScholarGoogle Scholar |
[2] Abbasakoor F, Boulos PB. Anal intraepithelial neoplasia. Br J Surg 2005; 92 277–90.
| Anal intraepithelial neoplasia.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BD2M7hslyhtw%3D%3D&md5=a107342170bfa1098b581ed96675cbb7CAS |
[3] Johnson LG, Madeleine MM, Newcomer LM, Schwartz SM, Daling JR. Anal cancer incidence and survival: the surveillance, epidemiology, and end results experience, 1973–2000. Cancer 2004; 101 281–8.
| Anal cancer incidence and survival: the surveillance, epidemiology, and end results experience, 1973–2000.Crossref | GoogleScholarGoogle Scholar |
[4] Grulich AE, Jin F, Conway EL, Stein AN, Hocking J. Cancers attributable to human papillomavirus infection. Sex Health 2010; 7 244–52.
| Cancers attributable to human papillomavirus infection.Crossref | GoogleScholarGoogle Scholar |
[5] American Cancer Society. Cancer facts & figures, 2009. Atlanta: American Cancer Society; 2009.
[6] Palefsky JM. Anal cancer prevention in HIV-positive men and women. Curr Opin Oncol 2009; 21 433–8.
| Anal cancer prevention in HIV-positive men and women.Crossref | GoogleScholarGoogle Scholar |
[7] Greene MD. Diagnosis and management of HPV-related anal dysplasia. Nurse Pract 2009; 34 45–51.
| Diagnosis and management of HPV-related anal dysplasia.Crossref | GoogleScholarGoogle Scholar |
[8] Fox PA, Seet JE, Stebbing J, Francis N, Barton SE, Strauss S, et al The value of anal cytology and human papillomavirus typing in the detection of anal intraepithelial neoplasia: a review of cases from an anoscopy clinic. Sex Transm Infect 2005; 81 142–6.
| The value of anal cytology and human papillomavirus typing in the detection of anal intraepithelial neoplasia: a review of cases from an anoscopy clinic.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BD2M7mvVyiuw%3D%3D&md5=8bf271d98ba5304d301384ad58d0faf9CAS |
[9] Friedlander MA, Stier E, Lin O. Anorectal cytology as a screening tool for anal squamous lesions: cytologic, anoscopic, and histologic correlation. Cancer 2004; 102 19–26.
| Anorectal cytology as a screening tool for anal squamous lesions: cytologic, anoscopic, and histologic correlation.Crossref | GoogleScholarGoogle Scholar |
[10] Palefsky JM, Holly EA, Hogeboom CJ, Berry JM, Jay N, Darragh TM. Anal cytology as a screening tool for anal squamous intraepithelial lesions. J Acquir Immune Defic Syndr Hum Retrovirol 1997; 14 415–22.
| Anal cytology as a screening tool for anal squamous intraepithelial lesions.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DyaK2szhsVSksQ%3D%3D&md5=e3e9bcaa93f2aeeaf61f1785603d8598CAS |
[11] Palefsky JM, Holly EA, Ralston ML, Jay N, Berry JM, Darragh TM. High incidence of anal high-grade squamous intra-epithelial lesions among HIV-positive and HIV-negative homosexual and bisexual men Aids 1998; 12 495–503.
| High incidence of anal high-grade squamous intra-epithelial lesions among HIV-positive and HIV-negative homosexual and bisexual menCrossref | GoogleScholarGoogle Scholar | 1:STN:280:DyaK1c3gt1Cmsg%3D%3D&md5=b7f4741b58fd5e30b1f291bac0342197CAS |
[12] Chin-Hong PV, Palefsky JM. Natural history and clinical management of anal human papillomavirus disease in men and women infected with human immunodeficiency virus. Clin Infect Dis 2002; 35 1127–34.
| Natural history and clinical management of anal human papillomavirus disease in men and women infected with human immunodeficiency virus.Crossref | GoogleScholarGoogle Scholar |
[13] Chiao EY, Giordano TP, Palefsky JM, Tyring S, El Serag H. Screening HIV-infected individuals for anal cancer precursor lesions: a systematic review. Clin Infect Dis 2006; 43 223–33.
| Screening HIV-infected individuals for anal cancer precursor lesions: a systematic review.Crossref | GoogleScholarGoogle Scholar |
[14] Mathews WC. Screening for anal dysplasia associated with human papillomavirus. Topics in HIV Med 2003; 11 45–9.
[15] Anderson JS, Vajdic C, Grulich AE. Is screening for anal cancer warranted in homosexual men? Sex Health 2004; 1 137–40.
| Is screening for anal cancer warranted in homosexual men?Crossref | GoogleScholarGoogle Scholar |
[16] Sobhani I, Vuagnat A, Walker F, Vissuzaine C, Mirin B, Hervatin F, et al Prevalence of high-grade dysplasia and cancer in the anal canal in human papillomavirus-infected individuals. Gastroenterology 2001; 120 857–66.
| Prevalence of high-grade dysplasia and cancer in the anal canal in human papillomavirus-infected individuals.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BD3M7mtVarsg%3D%3D&md5=ad5ba2f790b5a131c4ad4399fb912d01CAS |
[17] Edgren G, Sparen P. Risk of anogenital cancer after diagnosis of cervical intraepithelial neoplasia: a prospective population-based study. Lancet Oncol 2007; 8 311–6.
| Risk of anogenital cancer after diagnosis of cervical intraepithelial neoplasia: a prospective population-based study.Crossref | GoogleScholarGoogle Scholar |
[18] Scholefield JH, Sonnex C, Talbot IC, Palmer JG, Whatrup C, Mindel A, et al Anal and cervical intraepithelial neoplasia: possible parallel. Lancet 1989; 334 765–9.
| Anal and cervical intraepithelial neoplasia: possible parallel.Crossref | GoogleScholarGoogle Scholar |
[19] Evans HS, Newnham A, Hodgson SV, Moller H. Second primary cancers after cervical intraepithelial neoplasia III and invasive cervical cancer in southeast England. Gynecol Oncol 2003; 90 131–6.
| Second primary cancers after cervical intraepithelial neoplasia III and invasive cervical cancer in southeast England.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BD3s3psVWgsA%3D%3D&md5=29b9d31e6c6cfc864e31a5b3f7648061CAS |
[20] Dixon AR, Pringle JH, Holmes JT, Watkin DF. Cervical intraepithelial neoplasia and squamous cell carcinoma of the anus in sexually active women. Postgrad Med J 1991; 67 557–9.
| Cervical intraepithelial neoplasia and squamous cell carcinoma of the anus in sexually active women.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DyaK38%2FitVGjtw%3D%3D&md5=8cd8058b5479acb13713185e8574bf79CAS |
[21] Wong S, Gibbs P, Chao M, Jones I, McLaughlin S, Tjandra J, et al Carcinoma of the anal canal: a local experience and review of the literature. ANZ J Surg 2004; 74 541–6.
| Carcinoma of the anal canal: a local experience and review of the literature.Crossref | GoogleScholarGoogle Scholar |
[22] Lee JS, Rieger NA, Stephens JH, Hewett PJ, Rodda DJ, Lawrence MJ. Six-year prospective analysis of the rectal bleeding clinic at the Queen Elizabeth Hospital, Adelaide, South Australia. ANZ J Surg 2007; 77 553–6.
| Six-year prospective analysis of the rectal bleeding clinic at the Queen Elizabeth Hospital, Adelaide, South Australia.Crossref | GoogleScholarGoogle Scholar |
[23] McCloskey JC, Metcalf C, French MA, Flexman JP, Burke V, Beilin LJ. The frequency of high-grade intraepithelial neoplasia in anal/perianal warts is higher than previously recognized. Int J STD AIDS 2007; 18 538–42.
| The frequency of high-grade intraepithelial neoplasia in anal/perianal warts is higher than previously recognized.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BD2svmvVeguw%3D%3D&md5=bb857598144c071967789995f5e1b38aCAS |
[24] Young SC, Solomon MJ, Hruby G, Frizelle FA. Review of 120 anal cancer patients. Colorectal Dis 2008; 11 909–14.
| Review of 120 anal cancer patients.Crossref | GoogleScholarGoogle Scholar |
[25] Wang ML, Heriot A, Leong T, Ngan SY. Chemoradiotherapy in the management of primary squamous-cell carcinoma of the rectum. Colorectal Dis 2009; 13 296–301.
| Chemoradiotherapy in the management of primary squamous-cell carcinoma of the rectum.Crossref | GoogleScholarGoogle Scholar |
[26] Australian Bureau of Statistics (ABS). Population by age and sex, regions of Australia 2009: Tasmania. Canberra: Australian Bureau of Statistics; 2010. Available online at: http://www.abs.gov.au/ausstats/abs@.nsf/Products/3235.0~2009~Main+Features~Tasmania?OpenDocument#PARALINK0 [verified June 2011].
[27] World Health Organization (WHO). International classification of disease version 10. Geneva: WHO; 2007. Available online at: http://apps.who.int/classifications/apps/icd/icd10online/ [verified July 2011].
[28] Welton ML, Lambert R, Bosman FT. 9–1. Tumours of the anal canal. In: Bosman FT, Carneiro F, Hruban RH, Theise ND, editors. WHO classification of tumours of the digestive System, 4th edition. Lyon: International Agency for Research on Cancer; 2010.
[29] Edge S, editor. AJCC cancer staging manual, 7th edition. New York: Springer; 2010.
[30] Grulich AE, de Visser RO, Smith AM, Rissel CE, Richters J. Sex in Australia: homosexual experience and recent homosexual encounters. Aust N Z J Public Health 2003; 27 155–63.
| Sex in Australia: homosexual experience and recent homosexual encounters.Crossref | GoogleScholarGoogle Scholar |
[31] de Visser RO, Smith AM, Rissel CE, Richters J, Grulich AE. Sex in Australia: heterosexual experience and recent heterosexual encounters among a representative sample of adults. Aust N Z J Public Health 2003; 27 146–54.
| Sex in Australia: heterosexual experience and recent heterosexual encounters among a representative sample of adults.Crossref | GoogleScholarGoogle Scholar |
[32] Moscicki AB, Schiffman M, Kjaer S, Villa LL. Chapter 5: updating the natural history of HPV and anogenital cancer. Vaccine 2006; 24 S42–51.
| Chapter 5: updating the natural history of HPV and anogenital cancer.Crossref | GoogleScholarGoogle Scholar |
[33] Shia J. An update on tumors of the anal canal. Arch Pathol Lab Med 2010; 134 1601–11.
